ОПРЕДЕЛЕНИЕ ХИМИЧЕСКОГО СОСТАВА ВТОРИЧНЫХ МЕТАБОЛИТОВ ЭНДОФИТНОГО ГРИБА RHIZOPUS SP., ИЗОЛИРОВАННОГО ИЗ РАСТЕНИЯ ZIZIPHORA PEDICELLATUM PAZIJ ET VVED
Мардиева К. ., Хамдамов Д. . & Эшбоев Ф. .
Annotatsiya
В данном исследовании проведено определение химического состава вторичных метаболитов эндофитного гриба Rhizopus sp., изолированного из растения Ziziphora pedicellatum Pazij et Vved, с использованием метода высокоэффективной жидкостной хроматографии, сопряжённой с тандемной масс-спектрометрией (LC–MS/MS). В результате анализа было идентифицировано несколько групп биологически активных соединений, включая микотоксины, фурокумарины, алкалоиды, фенольные кислоты и гликозиды. Среди обнаруженных метаболитов охратоксин A, оксипеуцеданин метанолат, геракленин и 5-аллилоксипсорален проявили выраженную антибактериальную и противоопухолевую активность против Staphylococcus aureus, Escherichia coli и опухолевых клеточных линий (HeLa, HepG2, MCF-7). Дополнительно выявленные соединения, такие как горденин, салицин и 3,4-дигидрокси-β-фенилпропионовая кислота, характеризуются антиоксидантными и противовоспалительными свойствами. Результаты исследования свидетельствуют о высоком биотехнологическом потенциале эндофитного штамма Rhizopus sp. как перспективного источника природных биологически активных веществ, обладающих антимикробной, антиоксидантной и противоопухолевой активностью.
Adabiyotlar
- World Health Organization (WHO). (2023). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2023. Geneva: WHO. Available at: https://www.who.int/publications/i/item/9789240077502
- Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Aguilar, G. R., Gray, A., et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
- de Kraker, M. E. A., Stewardson, A. J., & Harbarth, S. (2016). Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Medicine, 13(11), e1002184. https://doi.org/10.1371/journal.pmed.1002184
- Antimicrobial Resistance Collaborators. (2023). Global burden of bacterial antimicrobial resistance 1990–2021: a comprehensive analysis. The Lancet, 402(10419), 2232–2251. https://doi.org/10.1016/S0140-6736(23)02058-6
- World Health Organization (WHO). (2019). New report calls for urgent action to avert antimicrobial resistance crisis. Geneva: WHO. Available at: https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis
- Newman, D. J., & Cragg, G. M. (2020). Natural products as sources of new drugs over the nearly four decades from 1981 to 2019. Journal of Natural Products, 83(3), 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
- Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Supuran, C. T., & International Natural Product Sciences Taskforce. (2021). Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery, 20(3), 200–216. https://doi.org/10.1038/s41573-020-00114-z
- Bérdy, J. (2012). Thoughts and facts about antibiotics: where we are now and where we are heading. Journal of Antibiotics, 65(8), 385–395. https://doi.org/10.1038/ja.2012.27
- Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015). The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug Discovery, 14(2), 111–129. https://doi.org/10.1038/nrd4510
- Shen, B. (2015). A new golden age of natural products drug discovery. Cell, 163(6), 1297–1300. https://doi.org/10.1016/j.cell.2015.11.031
- Lahlou, M. (2013). The success of natural products in drug discovery. Pharmacology & Pharmacy, 4(3), 17–31. https://doi.org/10.4236/pp.2013.43A003
- Strobel, G. A. (2018). Endophytes as sources of bioactive products. Microbes and Infection, 20(10), 560–568. https://doi.org/10.1016/j.micinf.2018.01.002
- Venugopalan, A., & Srivastava, S. (2015). Endophytes as in vitro production platforms of high value plant secondary metabolites. Biotechnology Advances, 33(6), 873–887. https://doi.org/10.1016/j.biotechadv.2015.07.004
- Gouda, S., Das, G., Sen, S. K., Shin, H.-S., & Patra, J. K. (2016). Endophytes: A treasure house of bioactive compounds of medicinal importance. Frontiers in Microbiology, 7, 1538. https://doi.org/10.3389/fmicb.2016.01538
- Hardoim, P. R., van Overbeek, L. S., & van Elsas, J. D. (2008). Properties of bacterial endophytes and their proposed role in plant growth. Trends in Microbiology, 16(10), 463–471. https://doi.org/10.1016/j.tim.2008.07.008
- Nicoletti, R., & Fiorentino, A. (2015). Plant bioactive metabolites and drugs produced by endophytic fungi of Spermatophyta. Agriculture, 5(4), 918–970. https://doi.org/10.3390/agriculture5040918
- Mousa, W. K., & Raizada, M. N. (2013). The diversity of anti-microbial secondary metabolites produced by fungal endophytes: An interdisciplinary perspective. Frontiers in Microbiology, 4, 65. https://doi.org/10.3389/fmicb.2013.00065
- Savi, D. C., Shaaban, K. A., & Pupo, M. T. (2019). Fungal endophytes: Sources of natural products and perspectives for biotechnological use. Current Opinion in Biotechnology, 59, 15–23. https://doi.org/10.1016/j.copbio.2019.02.003
- Chandra, S. (2012). Endophytic fungi: Novel sources of anticancer lead molecules. Applied Microbiology and Biotechnology, 95(1), 47–59. https://doi.org/10.1007/s00253-012-4128-7
- Strobel, G., Daisy, B., Castillo, U., & Harper, J. (2004). Natural products from endophytic microorganisms. Journal of Natural Products, 67(2), 257–268. https://doi.org/10.1021/np030397v
- Puri, S. C., Verma, V., Amna, T., Qazi, G. N., & Spiteller, M. (2005). An endophytic fungus from Taxus wallichiana and its taxol production. FEMS Microbiology Letters, 251(2), 291–297. https://doi.org/10.1016/j.femsle.2005.08.023
- Shweta, S., Zuehlke, S., Ramesha, B. T., Priti, V., Kumar, P. M., Ravikanth, G., et al. (2010). Endophytic fungal strains of Fusarium solani, from Apodytes dimidiata E. Mey. ex Arn (Icacinaceae), produce camptothecin, 10-hydroxycamptothecin and 9-methoxycamptothecin. Phytochemistry, 71(1), 117–122. https://doi.org/10.1016/j.phytochem.2009.09.029
- Eshboev, F.; Karakozova, M.; Abdurakhmanov, J.; Bobakulov, K.; Dolimov, K.; Abdurashidov, A.; Baymirzaev, A.; Makhnyov, A.; Terenteva, E.; Sasmakov, S.; et al. Antimicrobial and Cytotoxic Activities of the Secondary Metabolites of Endophytic Fungi Isolated from the Medicinal Plant Hyssopus Officinalis. Antibiotics 2023, 12, 1201.
- Schmid, R.; Heuckeroth, S.; Korf, A.; Smirnov, A.; Myers, O.; Dyrlund, T.S.; Bushuiev, R.; Murray, K.J.; Hoffmann, N.; Lu, M.; et al. Integrative Analysis of Multimodal Mass Spectrometry Data in MZmine 3. Nat. Biotechnol. 2023, 41, 447–449.
- Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and community curation of mass spectrometry data with global natural products social molecular networking. Nat. Biotechnol. 2016, 34, 828–837.
- Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498–2504.
- Creppy EE, Lugnier A, Fasiolo F, Heller K, Röschenthaler R, Dirheimer G. In vitro inhibition of yeast phenylalanyl-tRNA synthetase by ochratoxin A. Chem Biol Interact. 1979;24(2):257–261.
- Creppy EE, Röschenthaler R, Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem Toxicol. 1984;22(11):883–886.
- Ding L, et al. Ochratoxin A: Overview of Prevention, Removal, and Toxicity. Toxins. 2023;15(9):565.
- Park SH, Hong J-Y, Park HJ, Lee SK. The antiproliferative activity of oxypeucedanin via induction of G₂/M phase cell cycle arrest and p53-dependent MDM2/p21 expression in human hepatoma cells. Molecules. 2020;25(3):501.
- Mottaghipisheh J, et al. Oxypeucedanin: Chemotaxonomy, isolation, and bioactivities. Plants. 2021;10(8):1577.
- Kaya HO, et al. Electrochemical profiling of natural furanocoumarins: DNA interaction dynamics of oxypeucedanin and prantschimgin. ADMET DMPK. 2024;12(2):319–334.
- Ha A, Kim SJ, Shim SR, Kim YK, Jung JH. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis. Ophthalmology. 2022 Mar;129(3):322-333. doi: 10.1016/j.ophtha.2021.10.016. Epub 2021 Oct 22. PMID: 34688698.
- Vidyavarsha SJ, et al. In-vitro antibacterial activity of andrographolide and hordenine. J Vet Anim Sci. 2022;53:407–412.
- Zhang X, et al. Hordenine protects against LPS-induced acute lung injury. Front Pharmacol. 2021;12:712232.
- Xu Z, et al. Beneficial effects of hordenine on ulcerative colitis. Molecules. 2023;28(6):2834.
- Grant GE, Rokach J, Powell WS. 5-Oxo-ETE and the OXE receptor. Prostaglandins Other Lipid Mediat. 2009 Sep;89(3-4):98-104. doi: 10.1016/j.prostaglandins.2009.05.002. Epub 2009 May 18. PMID: 19450703; PMCID: PMC2906239.
- O‘Flaherty JT, Rogers LC, Paumi CM, Hantgan RR, Thomas LR, Clay CE, High K, Chen YQ, Willingham MC, Smitherman PK, Kute TE, Rao A, Cramer SD, Morrow CS. 5-Oxo-ETE analogs and the proliferation of cancer cells. Biochim Biophys Acta. 2005 Oct 1;1736(3):228-36. doi: 10.1016/j.bbalip.2005.08.009. Epub 2005 Aug 30. PMID: 16154383.
- Tanew A, Ortel B, Rappersberger K, Hönigsmann H. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation. J Am Acad Dermatol. 1988 Feb;18(2 Pt 1):333-8. PMID: 3279089.
- V. P. Santhana Krishnan, G. Karthikeyan, P. Janaki, B. Poonkodi, R. Sathya, Isolation of Heraclenin from Aegle marmelos correa and Screening for its Antimicrobial Activity Through in vitro & in silico Studies, The Natural Products Journal; Volume 6, Issue 2, Year 2016, DOI: 10.2174/2210315506999160510125407
- Shara M, Stohs SJ. Efficacy and Safety of White Willow Bark (Salix alba) Extracts. Phytother Res. 2015 Aug;29(8):1112-6. doi: 10.1002/ptr.5377. Epub 2015 May 22. PMID: 25997859.
- Mo, X.; Rao, D.P.; Kaur, K.; Hassan, R.; Abdel-Samea, A.S.; Farhan, S.M.; Bräse, S.; Hashem, H. Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024). Molecules 2024, 29, 4770. https://doi.org/10.3390/molecules29194770
- Li R, Xie L, Li L, Chen X, Yao T, Tian Y, Li Q, Wang K, Huang C, Li C, Li Y, Zhou H, Kaplowitz N, Jiang Y, Chen P. The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice. Acta Pharm Sin B. 2022 Jan;12(1):182-196. doi: 10.1016/j.apsb.2021.05.029. Epub 2021 Jun 1. PMID: 35127379; PMCID: PMC8799880.
- Catalán, M.; Ferreira, J.; Carrasco-Pozo, C. The Microbiota-Derived Metabolite of Quercetin, 3,4-Dihydroxyphenylacetic Acid Prevents Malignant Transformation and Mitochondrial Dysfunction Induced by Hemin in Colon Cancer and Normal Colon Epithelia Cell Lines. Molecules 2020, 25, 4138. https://doi.org/10.3390/molecules25184138